AI-assisted spirometry, imaging biomarkers, and population screening strategies highlighted early detection and prevention as a throughline at the ERS Congress. Artificial intelligence–supported ...

This research document defines 'disease stability' as a new therapeutic indicator for chronic obstructive pulmonary disease (COPD) and verifies its clinical significance. Stability is presented as an ...

Francesca Polverino, MD, PhD, discusses COPD biomarkers, patient susceptibility, overtreatment risk, and the future of risk ...

AstraZeneca said its new drug for COPD showed benefits across a broad patient population in late-stage clinical trials, ...

A little-known chronic lung disease is silently emerging as a growing public health threat in the U.S. and around the world.

Background Pulmonary rehabilitation (PR) is the cornerstone of non-pharmacological treatment for chronic obstructive ...

November is National Chronic Obstructive Pulmonary Disease Awareness Month. It's time to raise awareness about lung disease within our communities. By understanding the causes, reducing our risk ...

The modified Medical Research Council questionnaire (mMRC) and COPD Assessment Test (CAT) are objective measures of symptoms in patients with COPD, said lead author Andrew J. Gangemi, MD, associate ...

Prevalence of chronic obstructive pulmonary disease (COPD) and the disease's burden varies significantly by state. Understanding this variation could help address public health gaps to ease the burden ...

Chronic obstructive pulmonary disease, or COPD, is an ongoing group of lung conditions that include chronic bronchitis and emphysema. COPD is the result of damaged lung tissue, which leads to ...

Insilico tested an experimental drug in people with a serious lung illness. The drug appeared to reverse aging in a small ...